The Food and Drug Administration on Friday approved two gene therapies to treat sickle cell disease, one of the which is the first CRISPR/Cas9-based treatment to win regulatory approval in the US. The ...
The gene-editing technology known as CRISPR has led to revolutionary changes in agriculture, health research and more. In research published in Nature Catalysis, scientists at Florida State University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback